Literature DB >> 21779917

The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients.

Erhan Tatar1, Meltem Sezis Demirci, Fatih Kircelli, Ozkan Gungor, Mustafa Yaprak, Gulay Asci, Ali Basci, Mehmet Ozkahya, Ercan Ok.   

Abstract

BACKGROUND/AIMS: The association between thyroid hormones and arterial stiffness is unclear. In this study, we investigated, for the first time in a large cohort of euthyroid peritoneal dialysis patients, the relationship between thyroid hormone levels and arterial stiffness.
METHODS: Fifty-seven patients were enrolled. Serum TSH, free T3 and free T4 levels were measured by chemiluminescence immunoassay method. Pulse wave analysis [augmentation index (AIx) and subendocardial viability ratio (SEVR)] were measured to assess arterial stiffness.
RESULTS: Mean age was 49 ± 12.3 years, and 56.1% were female. Mean TSH, fT3 and fT4 levels were 1.97 ± 0.99 mIU/ml, 2.80 ± 0.42 pg/ml and 1.22 ± 0.16 ng/dl, respectively. Mean AIx and SEVR were 22.3 ± 11.3 and 136 ± 21%, respectively. AIx was negatively correlated with residual urine volume (r = -0.372, P: 0.03) and fT3 levels (r = -0.382, P: 0.005). SEVR was correlated only with TSH level (r = -0.394, P: 0.003). In linear regression analysis adjusted for age, gender, history of diabetes and cardiovascular disease and residual diuresis, fT3 level (t = -3.949, P < 0.001) remained associated with AIx. Only TSH level (t = -2.409, P: 0.02) was related to SEVR.
CONCLUSION: Low serum fT3 level is associated with arterial stiffness, and high TSH level within the normal range is related to lower SEVR in euthyroid PD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779917     DOI: 10.1007/s11255-011-0034-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome.

Authors:  T Nagaya; M Fujieda; G Otsuka; J P Yang; T Okamoto; H Seo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients.

Authors:  Kyeong Ho Yun; Myung Ho Jeong; Seok Kyu Oh; Eun Mi Lee; Je Lee; Sang Jae Rhee; Nam Jin Yoo; Nam-Ho Kim; Young Keun Ahn; Jin-Won Jeong
Journal:  Int J Cardiol       Date:  2007-01-12       Impact factor: 4.164

4.  Low triiodothyronine and survival in end-stage renal disease.

Authors:  C Zoccali; F Mallamaci; G Tripepi; S Cutrupi; P Pizzini
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

5.  Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses.

Authors:  E M Kaptein; J M Weiner; W J Robinson; W S Wheeler; J T Nicoloff
Journal:  Clin Endocrinol (Oxf)       Date:  1982-06       Impact factor: 3.478

6.  Gender-related differences in the central arterial pressure waveform.

Authors:  C S Hayward; R P Kelly
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

7.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

8.  Acute effects of thyroid hormone on vascular smooth muscle.

Authors:  K Ojamaa; J D Klemperer; I Klein
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

9.  Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness.

Authors:  L Bartalena; S Brogioni; L Grasso; F Velluzzi; E Martino
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

10.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

View more
  19 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Thyrotropin and free thyroxine concentrations do not affect cardiovascular disease and mortality in euthyroid peritoneal dialysis patients.

Authors:  Sara Romero Pérez; Juan Jose Díez; María Auxiliadora Bajo; Pedro Iglesias; Cristina Grande; Gloria del Peso; Rosario Madero; Marta Ossorio; Rafael Selgas
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

3.  Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.

Authors:  Fabrice Mac-Way; Véronique Couture; Mihai S Utescu; Sophie Ignace; Sacha A De Serres; Renée-Claude Loignon; Karine Marquis; Richard Larivière; Mohsen Agharazii
Journal:  Int Urol Nephrol       Date:  2013-11-17       Impact factor: 2.370

4.  Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.

Authors:  Tae Ik Chang; Joo Young Nam; Sug Kyun Shin; Ea Wha Kang
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

5.  Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.

Authors:  Connie M Rhee; Steven Kim; Daniel L Gillen; Tolga Oztan; Jiaxi Wang; Rajnish Mehrotra; Sooraj Kuttykrishnan; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2015-01-29       Impact factor: 5.958

6.  Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data.

Authors:  Changxiao Xie; Mao Zeng; Zumin Shi; Shengping Li; Ke Jiang; Yong Zhao
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

7.  Hypothyroidism and mortality among dialysis patients.

Authors:  Connie M Rhee; Erik K Alexander; Ishir Bhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

Review 8.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

Review 9.  The interaction between thyroid and kidney disease: an overview of the evidence.

Authors:  Connie M Rhee
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

10.  Increased night heart rate is associated with worse large artery elasticity in chronic kidney disease patients.

Authors:  Yunkai Bai; Hua Xiao; Zhenhua Liu; Xiaoyan Huang; Xinkui Tian; Tao Wang; Xingwei Zhe
Journal:  Int Urol Nephrol       Date:  2013-04-11       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.